The SHOX2A gene is a key player in the intricate network of genetic regulation, contributing significantly to the developmental processes that sculpt the vertebrate embryo. The protein product of SHOX2A, a transcription factor, is pivotal in orchestrating the expression of downstream genes, guiding the formation of skeletal structures and the central nervous system among other critical roles. Understanding the regulation of SHOX2A is an area of considerable interest within the field of developmental biology, as it provides insight into the molecular choreography that underpins growth and morphogenesis. Chemical activators that can potentially induce the expression of SHOX2A offer a valuable toolset for probing the depth of this gene's role, as well as for exploring the broader landscape of gene regulation.
Investigations into the potential induction of SHOX2A expression have highlighted a diverse array of chemical compounds, each interfacing with cellular mechanisms in unique ways to upregulate this pivotal gene. Compounds such as retinoic acid, which is known for its profound influence on cell differentiation and embryonic development, could induce SHOX2A expression by engaging with nuclear retinoic acid receptors that bind to DNA response elements in the gene's promoter region. Similarly, epigenetic modifiers like 5-azacytidine and trichostatin A, which inhibit DNA methylation and histone deacetylation, respectively, may upregulate SHOX2A by unwinding the densely packed chromatin around the gene, thereby allowing transcription factors easier access to initiate transcription. On the other hand, signaling molecules such as forskolin operate by elevating cAMP levels, thus activating protein kinase A and subsequent transcription factors that could boost SHOX2A expression. Sodium butyrate, another example, may also increase SHOX2A transcription by promoting a more relaxed chromatin configuration, enhancing the transcriptional machinery's ability to engage with the gene. Collectively, these compounds represent a fascinating glimpse into the molecular symphony that regulates gene expression, with SHOX2A standing as a crucial note in the developmental concerto.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid could potentially upregulate SHOX2A by binding to retinoic acid receptors, which then bind to retinoic acid response elements in the SHOX2A gene promoter. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound might induce SHOX2A transcription by inhibiting DNA methyltransferases, thereby decreasing DNA methylation levels at the SHOX2A gene locus and promoting gene activation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
By inhibiting histone deacetylase, Trichostatin A could enhance the acetylation of histones near the SHOX2A promoter, leading to a more accessible chromatin structure and increased transcription. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin may stimulate SHOX2A expression by elevating intracellular cAMP levels, which in turn activate protein kinase A (PKA) and can lead to the activation of cAMP response element-binding protein (CREB) at the SHOX2A promoter. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-Estradiol could upregulate SHOX2A by engaging estrogen receptors that interact with estrogen response elements in the regulatory regions of the SHOX2A gene. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
This synthetic glucocorticoid may stimulate SHOX2A expression by binding to glucocorticoid receptors, which then translocate to the nucleus and bind to glucocorticoid response elements upstream of the SHOX2A gene. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride could potentially increase SHOX2A expression by inhibiting glycogen synthase kinase-3 (GSK-3), thereby activating the Wnt signaling pathway and possibly leading to the transcriptional activation of Wnt target genes including SHOX2A. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
As a histone deacetylase inhibitor, sodium butyrate might enhance SHOX2A gene transcription by promoting a relaxed chromatin state and increasing the accessibility of transcription factors to the SHOX2A promoter region. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
This MEK inhibitor could upregulate SHOX2A expression by interfering with the MAPK/ERK pathway, which may lead to changes in the phosphorylation state of transcription factors that control SHOX2A gene transcription. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Inhibiting TGF-beta signaling with a compound like SB 431542 could theoretically remove the suppressive effects of TGF-beta on SHOX2A, resulting in an increase in its expression. | ||||||